ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
98,265.54
0.52%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
-0.01%
Brent Oil
72.72
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Alkido Pharma Inc (AIKI) 銘柄情報

Alkido Pharma Inc

Alkido Pharma Inc (AIKI)

NASDAQ
3.56
0.00
(0.00%)
終了 12月21日 6:00AM
15分遅延
0.00
0.00
(0.00%)
取引時間後: -
15分遅延

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
3.56
買値
3.53
売値
3.98
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
19.028M
前日終値
3.56
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
5,345,000
配当利回り
-
PER
-0.38
1 株当たり利益 (EPS)
-4.28
歳入
2.04M
純利益
-22.88M

Alkido Pharma Inc について

AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin... AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. 詳細を表示

セクター
Security Brokers & Dealers
業界
Security Brokers & Dealers
ウェブサイト
www.dominariholdings.com
本社
Wilmington, Delaware, USA
設立
-

AIKI 最新ニュース

その他のニュース

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown" PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- Dominari Holdings Inc...

2023年6月21日
PR Newswire (US)

Dominari Holdings Appoints George Way Chief Financial Officer

Dominari Holdings Appoints George Way Chief Financial Officer PR Newswire NEW YORK, April 3, 2023 Experienced Finance Executive to Support Growth Strategy  NEW YORK, April 3, 2023 /PRNewswire/...

2023年4月3日
PR Newswire (US)

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Feb. 24, 2023 NEW YORK, Feb. 24, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

2023年2月24日
PR Newswire (US)

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec. 28, 2022 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

2022年12月28日
PR Newswire (US)

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma...

2022年12月22日
PR Newswire (US)

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire NEW YORK, Nov. 28, 2022 Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW...

2022年11月28日
PR Newswire (US)

AIkido Share Repurchase Continues

AIkido Share Repurchase Continues PR Newswire NEW YORK, Oct. 6, 2022 NEW YORK, Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

2022年10月6日
PR Newswire (US)

AIkido Purchases More Shares

AIkido Purchases More Shares PR Newswire NEW YORK, Oct. 5, 2022 NEW YORK, Oct. 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on...

2022年10月5日
PR Newswire (US)

Share Repurchase Program Continues

Share Repurchase Program Continues PR Newswire NEW YORK, Oct. 4, 2022 NEW YORK, Oct. 4, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

2022年10月4日
PR Newswire (US)

AIkido Pharma Continues Share Repurchase Program

AIkido Pharma Continues Share Repurchase Program PR Newswire NEW YORK, Oct. 3, 2022 NEW YORK, Oct. 3, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today...

2022年10月3日
PR Newswire (US)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AIKI - Frequently Asked Questions (FAQ)

What is the current Alkido Pharma share price?
The current share price of Alkido Pharma is US$ 3.56
How many Alkido Pharma shares are in issue?
Alkido Pharma has 5,345,000 shares in issue
What is the market cap of Alkido Pharma?
The market capitalisation of Alkido Pharma is USD 19.03M
What is the 1 year trading range for Alkido Pharma share price?
Alkido Pharma has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Alkido Pharma?
The price to earnings ratio of Alkido Pharma is -0.38
What is the cash to sales ratio of Alkido Pharma?
The cash to sales ratio of Alkido Pharma is 4.27
What is the reporting currency for Alkido Pharma?
Alkido Pharma reports financial results in USD
What is the latest annual turnover for Alkido Pharma?
The latest annual turnover of Alkido Pharma is USD 2.04M
What is the latest annual profit for Alkido Pharma?
The latest annual profit of Alkido Pharma is USD -22.88M
What is the registered address of Alkido Pharma?
The registered address for Alkido Pharma is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Alkido Pharma website address?
The website address for Alkido Pharma is www.dominariholdings.com
Which industry sector does Alkido Pharma operate in?
Alkido Pharma operates in the SECURITY BROKERS & DEALERS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

AIKI Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
AIKI
Alkido Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有